{
    "organizations": [],
    "uuid": "dee2c61a0144fb3601daeb14ac519107b24ddda5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vistagen-therapeutics-reports-qtrl/brief-vistagen-therapeutics-reports-qtrly-loss-per-share-0-25-idUSASB0C5AJ",
    "ord_in_thread": 0,
    "title": "BRIEF-VistaGen Therapeutics Reports Qtrly Loss Per Share $‍0.25​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - VistaGen Therapeutics Inc:\n* VISTAGEN THERAPEUTICS REPORTS THIRD QUARTER FISCAL 2018 FINANCIAL RESULTS\n* VISTAGEN THERAPEUTICS INC QTRLY LOSS PER SHARE $‍0.25​ * VISTAGEN THERAPEUTICS INC - ‍AT DEC 31, HAD CASH, CASH EQUIVALENTS OF ABOUT $13.0 MILLION, COMPARED TO ABOUT $2.9 MILLION AT MARCH 31, 2017​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T05:44:00.000+02:00",
    "crawled": "2018-02-13T15:59:13.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "vistagen",
        "therapeutic",
        "inc",
        "vistagen",
        "therapeutic",
        "report",
        "third",
        "quarter",
        "fiscal",
        "financial",
        "result",
        "vistagen",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "vistagen",
        "therapeutic",
        "inc",
        "dec",
        "cash",
        "cash",
        "equivalent",
        "million",
        "compared",
        "million",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}